OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review
Robert Kubina, Kamil Krzykawski, Agata Kabała‐Dzik, et al.
Nutrients (2022) Vol. 14, Iss. 13, pp. 2604-2604
Open Access | Times Cited: 39

Showing 26-50 of 39 citing articles:

Signaling pathways driving ocular malignancies and their targeting by bioactive phytochemicals
Courtney R. Croley, Joshua Pumarol, Blake E. Delgadillo, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108479-108479
Closed Access | Times Cited: 3

Natural Compounds and Healthy Foods: Useful Tools against Onset and Progression of Chronic Diseases
Antonella Amato
Nutrients (2023) Vol. 15, Iss. 13, pp. 2898-2898
Open Access | Times Cited: 3

Identification of ZINC08101049 as a potential IL1β inhibitor through molecular docking and MD simulations for cancer therapeutics
Mohammad Y. Alshahrani, Muath Suliman, Mohammad Ali Abdullah Almoyad, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access

Fisetin enhances cisplatin sensitivity in renal cell carcinoma via the CDK6/PI3K/Akt/mTOR signaling pathway
Tingting Jiang, Yan Liang, Y. Y. Ji, et al.
Oncology Letters (2024) Vol. 27, Iss. 4
Open Access

Inhibitors of CK2 Kinase for the Treatment of Gliomas and Other Brain Tumors
Emanuela Pucko, Robert P. Ostrowski
Acta Poloniae Pharmaceutica - Drug Research (2024) Vol. 81, Iss. 1, pp. 53-69
Open Access

Nutritional Strategy for Cancer—From Prevention to Aftercare
Jakub Klekowski, Mariusz Chabowski
Nutrients (2024) Vol. 16, Iss. 10, pp. 1437-1437
Open Access

The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review
Wei Yu, Yaping Zhao, Iqra Ilyas, et al.
Journal of Pharmacy and Pharmacology (2024) Vol. 77, Iss. 2, pp. 206-221
Closed Access

Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway
Amin Iranpanah, Mohammad Bagher Majnooni, Hossein Biganeh, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3736-3762
Closed Access

Advancements in Plant-Based Therapeutics for Hepatic Fibrosis: Molecular Mechanisms and Nanoparticulate Drug Delivery Systems
Alina Ciceu, Ferenc Fenyvesi, Anca Hermenean, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9346-9346
Open Access

Bioactive Compounds from Achyranthes Aspera L. Extract: A UHPLC Profile and In Silico Study for Mouth Cancer
Juveriya Israr, Tanveer Ahamad, Shabroz Alam, et al.
ChemistrySelect (2024) Vol. 9, Iss. 38
Open Access

Bifunctional Antidiabetic - Anticancer Dual - Active Phytochemicals: Adjuncts or Alternatives to Conventional Therapies
Ofodire Emeka
Advances in Bioengineering and Biomedical Science Research (2023) Vol. 6, Iss. 5
Open Access

Fisetin suppresses chondrocyte senescence and attenuates osteoarthritis progression by targeting SIRT6
Xuezhong Wang, Xuyang Li, Jianlin Zhou, et al.
Research Square (Research Square) (2023)
Open Access

Previous Page - Page 2

Scroll to top